A surge in dengue cases adds to the hospital burden in Covid-hit S. Asia

The latest wave of Covid-19 infections in South Asian nations has been complicated by a surge in dengue, a mosquito-transmitted virus. The rise in cases of dengue is adding to the load of hospitals that are already overwhelmed. Sri Lanka has reported over 17,000 cases this year, including 3,300 in July. Bangladesh has recorded about 4,500 cases of hospitalisation for dengue this year, nearly half of them in July. “The health system is already overburdened by Covid-19 patients,” said Dr. Himali Herath, a consultant physician at Sri Lanka’s National Dengue Control Unit. “Caring for dengue patients is labour-intensive. Therefore it will be very difficult.” The WHO estimates that there are hundreds of millions of dengue infections every year, and nearly two-thirds occur in Asia. There is no specific treatment for the virus, and severe cases can lead to death if not detected early and if patients do not receive adequate medical care.

“Due to the heavy stream of Covid-19 patients, we are turning dengue patients to other hospitals,” said Brig. Gen. Nazmul Haque, the director of the Dhaka Medical College Hospital in Bangladesh. “We are only treating the patients who are infected with both Covid and dengue.”

Dengue outbreaks also remain endemic in Nepal and Pakistan. In Kathmandu, Nepal’s capital, officials said the main hospital that treated dengue patients in previous years had been turned into a Covid hospital. The government lab where all suspected dengue cases would usually be referred to for testing has also been overwhelmed with coronavirus tests, they said.

  • Related Posts

    35 drugs manufactured in Telangana fail CDSCO quality checks

    Hyderabad:  As many as 35 drugs manufactured in Telangana and supplied to states including Himachal Pradesh and Uttarakhand were flagged over the past year by the Central Drugs Standard Control…

    Delhi govt inspects 25 firms, collects 55 samples in crackdown on spurious anticancer drugs

    New Delhi:  In a special enforcement drive against spurious and substandard anticancer drugs, Delhi government inspected 25 firms and collected 55 samples across the city, officials said on Monday. Directed…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    35 drugs manufactured in Telangana fail CDSCO quality checks

    35 drugs manufactured in Telangana fail CDSCO quality checks

    Delhi govt inspects 25 firms, collects 55 samples in crackdown on spurious anticancer drugs

    Delhi govt inspects 25 firms, collects 55 samples in crackdown on spurious anticancer drugs

    ‘Import of Refurbished Medical Devices’ Lobby has reared its Ugly Head

    ‘Import of Refurbished Medical Devices’ Lobby has reared its Ugly Head

    ‘Import of Refurbished Medical Devices’ Lobby has reared its Ugly Head

    ‘Import of Refurbished Medical Devices’ Lobby has reared its Ugly Head

    Jharkhand HC orders FIRover children being given HIV-infected blood during transfusions

    Jharkhand HC orders FIRover children being given HIV-infected blood during transfusions

    Narco Syndicate indulged in supply of Contraband NRX medicines dismantled, arrested two key operatives

    Narco Syndicate indulged in supply of Contraband NRX medicines dismantled, arrested two key operatives